Top Markets
#1 Siren Siren +44.15%
#2 Seeker Seeker +24.16%
#3 Full Moon Full Moon +19.19%
#4 Zora Zora +12.73%
#5 Wrapped NXM Wrapped NXM +12.47%
#6 VVS Finance VVS Finance +10.65%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.49%
#8 Axelar Axelar +9.87%
#9 Cryptopia Cryptopia +9.12%
#10 Helium Helium +8.16%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Jinling Pharmaceutical Company Limited Jinling Pharmaceutical Company Limited

Jinling Pharmaceutical Company Limited

000919
Rank in Stocks #12123
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in... Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
Share Price
$0.96947389
Market Cap
$602.94M
Change (1 day)
-2.34%
Change (1 year)
-2.77%
Country
CN
Trade Jinling Pharmaceutical Company Limited (000919)

Category

Healthcare
P/S ratio for Jinling Pharmaceutical Company Limited (000919)
P/S ratio as of 2026 TTM: 0
According to Jinling Pharmaceutical Company Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Jinling Pharmaceutical Company Limited from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US